Hsu Leigh James

Dr. Hsu has over 15 years of work experience in business management and strategic planning in the biotechnology industry. Prior to joining the Group, Dr. Hsu served as director of business development at Acadia Pharmaceuticals (NASDAQ: ACAD) and vice president of corporate development and strategy at Lpath, Inc. (NASDAQ: LPTN) between January 2005 and November 2016.

Dr. Hsu obtained his bachelor’s degree in biochemistry and cell biology and his doctorate degree in molecular pathology from the University of California, San Diego in the United States, in June 1993 and June 1999, respectively. He received his master’s degree in business administration from the University of California, Irvine in the United States, in June 2001.